Article

Advanced RCC benefits from multimodal approach

Patients with metastatic renal cell cancer historically have had a poorprognosis, and attempts with hormonal therapy and chemotherapy have haddisappointing results. In this exclusive Urology Times interview, W. MarstonLinehan, MD, discusses new treatment strategies for renal cell carcinoma,including multimodality therapy with surgery and systemic therapy, and adoptiveimmunotherapy. Dr. Linehan is chief of urologic surgery at the NationalCancer Institute, Bethesda, MD. UT Editorial Consultant Andrew C. Novick,MD, chairman of the Cleveland Clinic Urological Institute, conducted theinterview.

Related Videos
Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
1 expert is featured in this series.
1 expert is featured in this series.
Woman talking with a doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
2 experts are featured in this series.
2 experts are featured in this series.
Rebecca A. Campbell, MD, answers a question during a Zoom video interview
© 2025 MJH Life Sciences

All rights reserved.